820 related articles for article (PubMed ID: 18508188)
1. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
[TBL] [Abstract][Full Text] [Related]
2. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment on: Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
de la Rosette JJ
Eur Urol; 2009 Mar; 55(3):647-8. PubMed ID: 18508190
[No Abstract] [Full Text] [Related]
4. Editorial comment on: Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Cestari A; Guazzoni G
Eur Urol; 2009 Mar; 55(3):648-9. PubMed ID: 18508189
[No Abstract] [Full Text] [Related]
5. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
6. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
[TBL] [Abstract][Full Text] [Related]
7. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
Heidenreich A; Richter S; Thüer D; Pfister D
Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
[TBL] [Abstract][Full Text] [Related]
8. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results.
Berge V; Baco E; Karlsen SJ
Scand J Urol Nephrol; 2010 Sep; 44(4):223-7. PubMed ID: 20350272
[TBL] [Abstract][Full Text] [Related]
10. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
11. Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: prognostic value of prostate MRI.
Rouvière O; Sbihi L; Gelet A; Chapelon JY
Clin Radiol; 2013 Jul; 68(7):661-7. PubMed ID: 23485154
[TBL] [Abstract][Full Text] [Related]
12. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
[TBL] [Abstract][Full Text] [Related]
13. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
14. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
[TBL] [Abstract][Full Text] [Related]
15. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
[TBL] [Abstract][Full Text] [Related]
16. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
17. Control of prostate cancer by transrectal HIFU in 227 patients.
Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
[TBL] [Abstract][Full Text] [Related]
18. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
[TBL] [Abstract][Full Text] [Related]
19. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
[TBL] [Abstract][Full Text] [Related]
20. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.
Blana A; Murat FJ; Walter B; Thuroff S; Wieland WF; Chaussy C; Gelet A
Eur Urol; 2008 Jun; 53(6):1194-201. PubMed ID: 17997026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]